Filing Details

Accession Number:
0000899243-21-025738
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-24 16:16:10
Reporting Period:
2021-06-22
Accepted Time:
2021-06-24 16:16:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1840904 Atai Life Sciences N.v. ATAI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1845711 Ltd. Group Investment Apeiron 66 & 67, Beatrice, Amery Street
Sliema O1 SLM1707
No No Yes No
1860536 Presight Ii, Lp 66 & 67, Beatrice, Amery Street
Sliema O1 SLM1707
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2021-06-22 700,000 $15.00 20,185,200 No 4 P Indirect By Apeiron Investment Group Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Apeiron Investment Group Ltd.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 1,187,104 Indirect By Presight II, L.P.
Footnotes
  1. Apeiron Investment Group Ltd. is the co-managing member of Presight Capital Management I, LLC, which is the general partner of Presight II, L.P. Therefore, Apeiron Investment Group Ltd. may be deemed to share beneficial ownership of the Common Shares held by Presight II, L.P. Apeiron Investment Group Ltd. is owned and controlled by Christian Angermayer. Mr. Angermayer may be deemed to have beneficial ownership over the shares held by Apeiron Investment Group Ltd. and Presight II, L.P.